May 15, 2026 09:31AM Volitionrx Limited (VNRX) Misses Q1 EPS by 93c

Apr 23, 2026 08:12AM VolitionRx receives NYSE American approval for compliance plan

Apr 20, 2026 07:30AM VolitionRx launches online shop for recombinant nucleosome products

Apr 20, 2026 07:02AM D. Boral Capital Downgrades VolitionRX (VNRX) to Hold

Apr 6, 2026 06:52AM VolitionRX (VNRX) PT Lowered to $1 at H.C. Wainwright

Apr 2, 2026 08:40AM Benchmark Reiterates Hold Rating on VolitionRX (VNRX)

Mar 31, 2026 08:16AM VolitionRx secures $2.3 million non-dilutive funding from Belgium

Mar 30, 2026 08:13AM VolitionRx study finds elevated nucleosome levels in trauma patients

Mar 25, 2026 08:17AM Volition reports 95% detection rate for early-stage cancers

Feb 25, 2026 08:11AM VolitionRx advances cancer detection tech and veterinary diagnostics

Feb 10, 2026 08:07AM VolitionRx names Medical & Biological Laboratories as Japan distributor

Feb 9, 2026 05:27PM VolitionRx receives NYSE American non-compliance notice

Jan 20, 2026 08:26AM Volition adds two lab providers for canine cancer test

Jan 8, 2026 09:15AM VolitionRx secures $2 million funding from Lind Global Asset Management

Jan 8, 2026 08:46AM VolitionRx reports feline cancer test detects 80% of lymphomas

Dec 17, 2025 08:45AM VolitionRx receives first clinical order for cancer test

Nov 25, 2025 08:45AM VolitionRx sells first Nu.Q cancer assays to French hospital

Nov 21, 2025 12:29PM VolitionRX (VNRX) PT Lowered to $1 at Freedom Capital Markets

Nov 18, 2025 06:52AM VolitionRX (VNRX) PT Lowered to $1.50 at H.C. Wainwright

Sep 30, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)

Sep 29, 2025 09:31AM VolitionRx signs co-marketing deal with Hologic for discovery service

Sep 15, 2025 08:55AM Benchmark Reiterates Hold Rating on VolitionRX (VNRX)

Sep 10, 2025 07:32AM H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)

Sep 9, 2025 08:47AM VolitionRx signs licensing deal with Werfen for blood clot test

Jun 12, 2025 08:32AM Volitionrx Limited (VNRX) Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

Jun 9, 2025 04:31PM Jones Trading Starts VolitionRX (VNRX) at Buy

May 19, 2025 09:19AM Benchmark Reiterates Hold Rating on VolitionRX (VNRX)

May 16, 2025 07:09AM Volitionrx Limited (VNRX) Misses Q1 EPS by 2c

Apr 11, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)

Apr 8, 2025 09:36AM Benchmark Reiterates Hold Rating on VolitionRX (VNRX)

Mar 26, 2025 08:00AM Volitionrx Limited (VNRX) Prices $2.3M Share Offering

Mar 21, 2025 08:32AM Volitionrx (VNRX) says study shows Nu.Q Cancer immunoassay test in development detected a range of 21 different cancers

Mar 13, 2025 08:30AM Volitionrx Limited (VNRX) Signs first ever Nu.Q Vet Cancer Test Automation Agreement with Fujifilm Vet Systems

Jan 8, 2025 08:32AM Volitionrx Limited (VNRX) Issues Business Review 2024

Jan 8, 2025 08:32AM Volitionrx Limited (VNRX) Issues Business Review 2024

Dec 6, 2024 09:00AM Volitionrx Limited (VNRX) Announces Pricing of up to $1.9 Million Registered Direct Offering

Sep 30, 2024 04:10PM Volitionrx Limited (VNRX) Appoints Ethel Rubin to its Board

Aug 9, 2024 08:01AM Volitionrx Limited (VNRX) Prices $21.5M Share and Warrant Offering